Navigation Links
Cellectis to Present at Two Upcoming International Investor Conferences
Date:9/6/2011

PARIS, Sept. 6, 2011 /PRNewswire/ -- Cellectis (Alternext: ALCLS), the French genome engineering specialist, will present at the UBS Global Life Sciences Conference in New York City on September 20, 2011, and at the MidCap Event in Paris on September 22 & 23, 2011.

Marc Le Bozec, CFO, will present the activities and the development strategy of the Cellectis group at the UBS Global Life Sciences Conference at the Grand Hyatt New York hotel on Tuesday, September 20, 2011 at 11:30 am ET.

Andre Choulika, Chairman and CEO, and Marc Le Bozec, CFO, will present Cellectis at the MidCap Event at Palais Brongniart in Paris on September 22-23.

About Cellectis

Cellectis improves life by applying its genome engineering expertise to a broad range of applications, including agriculture, bioresearch and human therapeutics. Cellectis is listed on the NYSE-Euronext Alternext market (code: ALCLS) in Paris.

For further information about Cellectis, visit our website at: www.cellectis.com

Follow Cellectis on twitter : http://twitter.com/cellectis

Disclaimer

This press release and the information contained herein do not constitute an offer to sell or subscribe, or a solicitation of an offer to buy or subscribe, for shares in Cellectis in any country. This press release contains forward-looking statements that relate to the Company's objectives based on the current expectations and assumptions of the Company's management only and involve unforeseeable risk and uncertainties that could cause the Company to fail to achieve the objectives expressed by the forward-looking statements above.


'/>"/>
SOURCE Cellectis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Cellectis bioresearch Grants Recombinetics an Exclusive License Agreement for the Use of Targeted Nucleases in Large Livestock
2. Dr. Andrew Scharenberg, M.D., to Serve as Chief Scientific Officer for Cellectis therapeutics
3. TALEN® Access by Cellectis Bioresearch Receives "Most Innovative New Service 2011" Award at Life Science Awards
4. Cellectis bioresearch Appoints Wako as Exclusive Distributor of its Genome Customization Solutions in Japan
5. Cellectis and Caisse des Depots Sign Agreement on a Project for the Industrial Development of iPS Cells
6. Cellectis Receives Payment for License to Homologous Recombination Patents
7. Cellectis Publishes 2010 Financial Results
8. Cellectis and the Etablissement Francais du Sang Launch StemRed, a Program to Produce Red Blood Cells From Stem Cells
9. Cellectis bioresearch First to Launch Revolutionary Custom TAL Nuclease Service
10. Cellectis Meganuclease Technology Used to Efficiently Prevent Viral Infection
11. Cellectis bioresearch Announces the First TGCA Winner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... 23, 2017 /PRNewswire/ - Resverlogix Corp. ("Resverlogix" or the ... New Zealand based Phase 1 ... showed remarkable results in reducing inflamed protein biomarkers in ... It is believed that this is the first time ... type can be made between epigenetic regulation and its ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... Vice President, Preclinical Safety and Senior Director, Safety Pharmacology. Dr. Thomas earned ... , Dr. Thomas’ career as an academic and industry preclinical drug developer ...
(Date:1/23/2017)... , ... January 23, 2017 , ... ... at the Caribbean Neurosciences Symposium (CANS) annual meeting in Montego Bay, Jamaica from ... and host a hands-on workshop for surgeons to experience the simplicity of the ...
(Date:1/21/2017)... ... January 20, 2017 , ... G&L Scientific Inc, a leading ... http://www.gandlscientific.com ), has announced the opening of new offices in Cambridge, Massachusetts, strengthening ... contractors. This is the latest step in G&L’s expansion of its global clinical ...
Breaking Biology Technology:
(Date:1/6/2017)... BOULDER, Colo. , Jan. 5, 2017 /PRNewswire/ ... join the "Digital Life Alliance" established by iCarbonX, ... in 2015 to build a "Global Digital Health ... based on a combination of individual,s biological, behavioral ... Under the agreement between the companies, SomaLogic will ...
(Date:1/3/2017)... 3, 2017 Onitor, provider of digital health ... Track, an innovative biometric data-driven program designed to aid ... at the 2017 Consumer Electronics Show (CES) in ... the U.S., the World Health Organization (WHO), have identified ... adults who are overweight or obese. WHO also states ...
(Date:12/20/2016)... 2016   Valencell , the leading innovator ... STMicroelectronics (NYSE: STM), a global semiconductor leader serving ... today the launch of a new, highly accurate ... includes ST,s compact SensorTile turnkey multi-sensor ... sensor system. Together, SensorTile and Benchmark deliver the ...
Breaking Biology News(10 mins):